• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms.社论：帕金森病及帕金森综合征非运动症状的生物标志物
Front Neurol. 2023 Sep 11;14:1257064. doi: 10.3389/fneur.2023.1257064. eCollection 2023.
2
Comparative analysis of non-motor symptoms in patients with Parkinson's Disease and atypical parkinsonisms.帕金森病与非典型帕金森病患者非运动症状的对比分析。
Clin Neurol Neurosurg. 2020 Oct;197:106088. doi: 10.1016/j.clineuro.2020.106088. Epub 2020 Jul 15.
3
Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.帕金森病的运动和非运动特征可预测持续性药物诱导的帕金森病。
Parkinsonism Relat Disord. 2014 Jul;20(7):738-42. doi: 10.1016/j.parkreldis.2014.03.024. Epub 2014 Apr 1.
4
[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.[¹²³I]FP - CIT单光子发射计算机断层扫描（DaTSCAN）可能是区分帕金森病与血管性或药物性帕金森综合征的有用工具：一项荟萃分析。
Eur J Neurol. 2014 Nov;21(11):1369-e90. doi: 10.1111/ene.12444. Epub 2014 Apr 30.
5
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population.博洛尼亚帕金森病起病时运动与非运动前瞻性研究（BoProPark）：研究设计与人群
Neurol Sci. 2020 Sep;41(9):2531-2537. doi: 10.1007/s10072-020-04305-9. Epub 2020 Mar 26.
6
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis.脑脊液α-突触核蛋白种类作为帕金森病诊断和预后生物标志物的价值
Biomark Med. 2016;10(1):35-49. doi: 10.2217/bmm.15.107. Epub 2015 Dec 8.
7
Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms.帕金森病和非典型帕金森综合征中炎症生物标志物的发现。
BMC Neurol. 2020 Jan 17;20(1):26. doi: 10.1186/s12883-020-1608-8.
8
Case Report of a pathologically confirmed vascular parkinsonism with early cognitive impairment and Behavioral disturbance.血管性帕金森病病例报告：伴有早期认知障碍和行为障碍的病理性确诊
BMC Neurol. 2021 Jan 11;21(1):15. doi: 10.1186/s12883-020-02038-y.
9
Differentiating drug-induced parkinsonism from Parkinson's disease: an update on non-motor symptoms and investigations.药物性帕金森综合征与帕金森病的鉴别：非运动症状及检查的最新进展
Parkinsonism Relat Disord. 2014 Aug;20(8):808-14. doi: 10.1016/j.parkreldis.2014.05.011. Epub 2014 Jun 3.
10
The Influence of Serum Uric Acid Level on Non-Motor Symptoms Occurrence and Severity in Patients with Idiopathic Parkinson's Disease and Atypical Parkinsonisms-A Systematic Review.血清尿酸水平对特发性帕金森病和非典型帕金森病患者非运动症状发生和严重程度的影响——系统评价。
Medicina (Kaunas). 2021 Sep 16;57(9):972. doi: 10.3390/medicina57090972.

引用本文的文献

1
Clinically probable RBD is an early predictor of malignant non-motor Parkinson's disease phenotypes.临床疑似快速眼动睡眠行为障碍是恶性非运动性帕金森病表型的早期预测指标。
NPJ Parkinsons Dis. 2025 Jan 29;11(1):25. doi: 10.1038/s41531-025-00874-8.
2
Treatment of Parkinson's disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport.使用通过受体介导转运穿透血脑屏障的生物制剂治疗帕金森病。
Front Aging Neurosci. 2023 Nov 13;15:1276376. doi: 10.3389/fnagi.2023.1276376. eCollection 2023.

本文引用的文献

1
The Disease Modification Conundrum in Parkinson's Disease: Failures and Hopes.帕金森病中的疾病修饰难题：失败与希望
Front Aging Neurosci. 2022 Feb 28;14:810860. doi: 10.3389/fnagi.2022.810860. eCollection 2022.
2
Correction to: Unexpected (I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT.对以下内容的更正：意外的（I）FP-CIT单光子发射计算机断层扫描结果：SWIDD、SWEDD及所有多巴胺转运体（DAT）情况
J Neurol. 2022 Feb;269(2):771. doi: 10.1007/s00415-021-10923-w.
3
Prodromal Parkinson disease subtypes - key to understanding heterogeneity.前驱期帕金森病亚型——理解异质性的关键。
Nat Rev Neurol. 2021 Jun;17(6):349-361. doi: 10.1038/s41582-021-00486-9. Epub 2021 Apr 20.
4
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?帕金森病的疾病修饰和生物标志物研发：修订还是重建？
Neurology. 2020 Mar 17;94(11):481-494. doi: 10.1212/WNL.0000000000009107. Epub 2020 Feb 26.
5
Biomarkers for Parkinson's Disease: How Good Are They?帕金森病的生物标志物：它们有多好？
Neurosci Bull. 2020 Feb;36(2):183-194. doi: 10.1007/s12264-019-00433-1. Epub 2019 Oct 23.
6
Parkinson disease.帕金森病。
Eur J Neurol. 2020 Jan;27(1):27-42. doi: 10.1111/ene.14108. Epub 2019 Nov 27.
7
Non-motor features of Parkinson disease.帕金森病的非运动症状。
Nat Rev Neurosci. 2017 Jul;18(7):435-450. doi: 10.1038/nrn.2017.62. Epub 2017 Jun 8.
8
Biomarkers-A General Review.生物标志物——综述
Curr Protoc Pharmacol. 2017 Mar 17;76:9.23.1-9.23.17. doi: 10.1002/cpph.19.
9
MDS clinical diagnostic criteria for Parkinson's disease.帕金森病的MDS临床诊断标准。
Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424.
10
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.生物标志物与替代终点：首选定义及概念框架
Clin Pharmacol Ther. 2001 Mar;69(3):89-95. doi: 10.1067/mcp.2001.113989.

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms.

作者信息

Filippi Massimo, Balestrino Roberta, Agosta Federica

机构信息

Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Lombardy, Italy.

Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Front Neurol. 2023 Sep 11;14:1257064. doi: 10.3389/fneur.2023.1257064. eCollection 2023.

DOI:10.3389/fneur.2023.1257064
PMID:37767533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10520349/
Abstract
摘要